"It’s most effective in finding later-stage cancers, when tumors release more of that DNA. The study found that Shield only detected 13% of earlier-stage polyps."
Not a useful population screening test based on these statistics. Also not cheap. At least Shield has opened up the market. Competition is good - let the best one win.
"It’s most effective in finding later-stage cancers, when tumors...
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.3¢ |
Change
0.013(11.4%) |
Mkt cap ! $29.83M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 12.3¢ | 11.5¢ | $26.7K | 226.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 338 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 56400 | 1 |
View Market Depth
| Last trade - 12.27pm 11/11/2024 (20 minute delay) ? |
| RHY (ASX) Chart |